Hologic, Inc. (LON:0J5Q)
64.20
-0.52 (-0.80%)
At close: Sep 15, 2025
Hologic Revenue
Hologic had revenue of $1.02B USD in the quarter ending June 28, 2025, with 1.23% growth. This brings the company's revenue in the last twelve months to $4.04B, up 1.29% year-over-year. In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B, down -0.00%.
Revenue (ttm)
$4.04B
Revenue Growth
+1.29%
P/S Ratio
3.59
Revenue / Employee
$571.84K
Employees
7,063
Market Cap
10.58B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
Sep 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 24, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Hologic News
- 6 days ago - Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 12 days ago - Hologic Inc (HOLX) Set to Present at Morgan Stanley Global Healthcare Conference | HOLX stock news - GuruFocus
- 12 days ago - Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference - Business Wire
- 6 weeks ago - Hologic (HOLX) Q3 Revenue Beats 1% - The Motley Fool
- 6 weeks ago - Hologic, Inc. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - Hologic targets mid-single-digit organic revenue growth in 2026 as Breast Health rebounds and tariff mitigation advances - Seeking Alpha
- 6 weeks ago - Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Hologic raises annual profit forecast on diagnostic and surgical demand - Reuters